MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Keros Therapeutics, Inc. (KROS)

Keros Therapeutics, Inc. (KROS)

|||

Balance Sheets Overview

Current Ratio
2196.03%
Quick Ratio
2196.03%
Cash Ratio
2119.69%
Debt to Asset Ratio
8.79%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Treasury stock, at cost 21,126,7...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
257,606
281,497
287,415
693,472
Accounts receivable
0
400
3,567
3,492
Prepaid expenses and other current assets
7,027
6,530
22,202
22,343
Current income tax receivable
2,250
2,250
2,250
-
Total current assets
266,883
290,677
315,434
719,307
Operating lease right-of-use assets
15,553
16,205
16,841
17,463
Property and equipment, net
3,715
3,962
4,297
4,564
Restricted cash
1,449
1,449
1,449
1,449
Other long term assets
-
-
0
0
Total assets
287,600
312,293
338,021
742,783
Accounts payable
1,816
1,493
1,967
2,298
Current portion of operating lease liabilities
2,597
2,501
2,408
2,318
Deferred revenue
-
-
-
155
Current tax liability
-
-
-
4,147
Accrued expenses and other current liabilities
7,740
8,859
16,039
15,174
Total current liabilities
12,153
12,853
20,414
24,092
Operating lease liabilities, net of current portion
13,127
13,810
14,475
15,111
Total liabilities
25,280
26,663
34,889
39,203
Common stock, par value of 0.0001 per share 200,000,000 shares authorized as of june30, 2026 and december31, 2025 40,953,948 shares issued and 19,827,188 shares outstanding as of june30, 2026 and 40,670,466 shares issued and 19,543,706 shares outstanding as of december31, 2025
4
4
4
4
Treasury stock, at cost 21,126,760 shares as of june30, 2026 and december31, 2025
384,558
384,558
384,558
-
Additional paid-in capital
1,181,057
1,175,657
1,169,451
1,161,880
Accumulated deficit
-534,183
-505,473
-481,765
-458,304
Total stockholders' equity
262,320
285,630
303,132
703,580
Total liabilities and stockholders' equity
287,600
312,293
338,021
742,783
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$257,606K (-62.68%↓ Y/Y)Prepaid expenses andother current assets$7,027K (-73.76%↓ Y/Y)Current income taxreceivable$2,250K Total current assets$266,883K (-63.58%↓ Y/Y)Operating leaseright-of-use assets$15,553K (-13.94%↓ Y/Y)Property and equipment,net$3,715K (-23.18%↓ Y/Y)Restricted cash$1,449K (0.00%↑ Y/Y)Total assets$287,600K (-62.02%↓ Y/Y)Total liabilities andstockholders' equity$287,600K (-62.02%↓ Y/Y)Total stockholders'equity$262,320K (-62.88%↓ Y/Y)Total liabilities$25,280K (-49.87%↓ Y/Y)Accumulated deficit-$534,183K (-18.44%↓ Y/Y)Treasury stock, at cost21,126,760 shares as of...$384,558K Additional paid-in capital$1,181,057K (2.01%↑ Y/Y)Operating leaseliabilities, net of current...$13,127K (-16.52%↓ Y/Y)Total currentliabilities$12,153K (-64.98%↓ Y/Y)Common stock, par valueof 0.0001 per share...$4K (0.00%↑ Y/Y)Accrued expenses andother current...$7,740K (-61.23%↓ Y/Y)Current portion ofoperating lease...$2,597K (16.46%↑ Y/Y)Accounts payable$1,816K (-65.52%↓ Y/Y)